Federal regulators on Thursday approved a new higher-dose version of the blockbuster obesity drug Wegovy that may help users lose more weight and keep it off. The U.S. Food and Drug Administration approved a 7.2-milligram dose of Danish drugmaker Novo Nordisk’s semaglutide. Previously, the highest approved dose of the drug, taken as a weekly shot, was 2.4 […]
About the Author
Discover more from USA NEWS
Subscribe to get the latest posts sent to your email.
